Clinical Trial Update: Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of S 95005 in combination with oxaliplatin for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S 95005 (S95005)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED